PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsHarmony Biosciences Holdings
Harmony Biosciences Holdings(HRMY)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
WakixPitolisant2019-08-142026-2030
Obstructive sleep apnea
,
Narcolepsy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pitolisant
narcolepsy
,
myotonic dystrophy
,
disorders of excessive somnolence
,
prader-willi syndrome
,
sleepiness
,
idiopathic hypersomnia
,
problem behavior
,
restless legs syndrome
,
psychomotor agitation
,
syndrome
,
cataplexy
,
pregnancy rate
Losartan
diabetic nephropathies
,
kidney diseases
,
proteinuria
,
type 2 diabetes mellitus
,
retinal diseases
,
renal insufficiency
,
essential hypertension
Aspartame
infections
,
postoperative complications
,
wounds and injuries
,
communicable diseases
,
joint diseases
,
musculoskeletal diseases
,
surgical wound
,
prosthesis-related infections
,
pathologic processes
Clemizole
hepatitis c
,
hepatitis
,
hepatitis a
,
colorectal neoplasms
,
colonic polyps
,
adenomatous polyps
,
depression
,
major depressive disorder
,
depressive disorder
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
immunoglobulin light-chain amyloidosis
,
amyloidosis
,
myoclonic epilepsies
,
seizures
,
fever
,
lennox gastaut syndrome
,
malaria
,
falciparum malaria
,
post-traumatic stress disorders
,
traumatic stress disorders
,
neoplasms
,
lung neoplasms
,
eye abnormalities
,
bone marrow examination
Phenylacetic acid
hyperkinesis
,
attention deficit disorder with hyperactivity
Zyn002
drug interactions
,
digeorge syndrome
,
22q11 deletion syndrome
,
fragile x syndrome
,
syndrome
Gluconorm
healthy volunteers/patients
,
drug interactions
,
obesity
,
mitochondrial diseases
,
stroke
,
hypersensitivity
,
parkinson disease
,
recurrence
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
gastrointestinal stromal tumors
,
lymphoma
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
malaria
,
rheumatoid arthritis
,
arthritis
,
sickle cell anemia
,
hyperuricemia
,
renal insufficiency
,
overweight
,
neoplasms
,
colorectal neoplasms
,
melanoma
,
uveal neoplasms
,
uveal melanoma
,
hypoglycemia
,
fibrosis
,
cystic fibrosis
,
hypertension
,
cardiovascular diseases
,
chronic renal insufficiency
,
kidney diseases
,
hypercholesterolemia
,
coronary disease
,
atherosclerosis
,
type 2 diabetes mellitus
,
diabetes mellitus
,
diabetes complications
,
morbid obesity
,
bariatric surgery
,
pancreatitis
,
pancreatic neoplasms
,
heart failure
,
prediabetic state
,
glucose intolerance
,
exocrine pancreatic insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use